Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
1.170
+0.485 (70.78%)
At close: Jul 15, 2025, 4:00 PM
0.9901
-0.1800 (-15.38%)
After-hours: Jul 15, 2025, 8:00 PM EDT
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $19.71 million as of July 15, 2025.
Market Cap
19.71M
Enterprise Value
16.10M
1-Year Change
n/a
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $19.71M, a decrease of -40.96%. That is a compound annual growth rate of -47.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2025 | 19.71M | 0.96% |
| Dec 31, 2024 | 19.53M | -41.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |